EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The cholinergic system exerts opposing effects on memory at different stages of disease progression in Alzheimer's and Down syndrome model systems

Christos Panagiotis Lisgaras iD, Helen E Scharfman iD

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Christos Panagiotis Lisgaras und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Memory, Memory Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, CURE Epilepsy Award, New York State Office of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The long‐standing cholinergic hypothesis posits that cholinergic signaling is uniformly deficient in Alzheimer's disease (AD) and Down syndrome (DS). We tested the hypothesis that this deficiency occurs primarily late in disease, while early stages involve excessive cholinergic signaling, with distinct implications for memory. METHODS Tg2576 (AD model; n = 38), Ts65Dn (DS model; n = 14), and wild‐type (WT; n = 17) mice at young (3 to 4 months) and old (>14 months) ages received treatments to reduce cholinergic signaling (medial septum chemogenetic inhibition, muscarinic antagonist scopolamine) or enhance it (acetylcholinesterase inhibitor donepezil). Memory assessments used novel object recognition. RESULTS Anticholinergic manipulations restored memory in young Tg2576 and Ts65Dn mice but impaired age‐matched WT mice. Conversely, donepezil improved the memory of old Tg2576, Ts65Dn, and WT but not young Tg2576 and Ts65Dn animals. DISCUSSION These findings refine and challenge the cholinergic hypothesis, revealing for the first time a functional shift from cholinergic hyperactivity driving early cognitive impairment to late‐stage degeneration requiring enhancement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeAlzheimer DiseaseMemoryMemory DisordersAnimalsDisease Models, AnimalDonepezilMice, TransgenicScopolamineCholinesterase InhibitorsIndansMiceDisease ProgressionPiperidinesMaleMuscarinic Antagonists

Stichwörter der Autor:innen

degenerationhyperexcitabilitymemory declinepharmacological interventionstreatment

Substanzen

DonepezilScopolamineCholinesterase InhibitorsIndansPiperidinesMuscarinic Antagonists

Autor:innen und Institutionen

  • Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.
  • The Nathan S. Kline Institute for Psychiatric Research, Center for Dementia Research, New York State Office of Mental Health, Orangeburg, New York, USA.
  • Departments of Child & Adolescent Psychiatry, Neuroscience & Physiology, and Psychiatry, and the NYU Neuroscience Institute, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Christos Panagiotis Lisgaras, Helen E Scharfman

Förderung

  • NIA NIH HHS
  • CURE Epilepsy Award
  • New York State Office of Mental Health
  • National Institute on Aging

Zitieren

APA

Lisgaras, C. P., & Scharfman, H. E. (2026). The cholinergic system exerts opposing effects on memory at different stages of disease progression in Alzheimer's and Down syndrome model systems. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71154

Vancouver

Lisgaras CP, Scharfman HE. The cholinergic system exerts opposing effects on memory at different stages of disease progression in Alzheimer's and Down syndrome model systems. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71154

BibTeX
@article{Lisgaras2026,
  author = {Lisgaras, Christos Panagiotis and Scharfman, Helen E},
  title = {The cholinergic system exerts opposing effects on memory at different stages of disease progression in Alzheimer's and Down syndrome model systems},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71154}
}
Kostenlos starten →